GB202112529D0 - New compounds - Google Patents

New compounds

Info

Publication number
GB202112529D0
GB202112529D0 GBGB2112529.9A GB202112529A GB202112529D0 GB 202112529 D0 GB202112529 D0 GB 202112529D0 GB 202112529 A GB202112529 A GB 202112529A GB 202112529 D0 GB202112529 D0 GB 202112529D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2112529.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Betagenon Bio AB
Original Assignee
Betagenon Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Betagenon Bio AB filed Critical Betagenon Bio AB
Priority to GBGB2112529.9A priority Critical patent/GB202112529D0/en
Publication of GB202112529D0 publication Critical patent/GB202112529D0/en
Priority to US18/684,154 priority patent/US20250136563A1/en
Priority to EP22792860.3A priority patent/EP4396171A1/en
Priority to MX2024002674A priority patent/MX2024002674A/es
Priority to CA3230307A priority patent/CA3230307A1/en
Priority to PCT/GB2022/052234 priority patent/WO2023031609A1/en
Priority to CN202280073480.7A priority patent/CN118510762A/zh
Priority to KR1020247010453A priority patent/KR20240055039A/ko
Priority to JP2024514006A priority patent/JP2024535745A/ja
Priority to AU2022336441A priority patent/AU2022336441A1/en
Priority to IL310871A priority patent/IL310871A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Peptides Or Proteins (AREA)
GBGB2112529.9A 2021-09-02 2021-09-02 New compounds Ceased GB202112529D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB2112529.9A GB202112529D0 (en) 2021-09-02 2021-09-02 New compounds
IL310871A IL310871A (en) 2021-09-02 2022-09-01 Thiadiazolone derivatives useful as ampk activator
CA3230307A CA3230307A1 (en) 2021-09-02 2022-09-01 Thiadiazolone derivatives useful as ampk activator
EP22792860.3A EP4396171A1 (en) 2021-09-02 2022-09-01 Thiadiazolone derivatives useful as ampk activator
MX2024002674A MX2024002674A (es) 2021-09-02 2022-09-01 Derivados de tiadiazolona utiles como activadores de ampk.
US18/684,154 US20250136563A1 (en) 2021-09-02 2022-09-01 Thiadiazolone derivatives useful as ampk activator
PCT/GB2022/052234 WO2023031609A1 (en) 2021-09-02 2022-09-01 Thiadiazolone derivatives useful as ampk activator
CN202280073480.7A CN118510762A (zh) 2021-09-02 2022-09-01 用作ampk激活剂的噻二唑酮衍生物
KR1020247010453A KR20240055039A (ko) 2021-09-02 2022-09-01 Ampk 활성화제로서 유용한 티아디아졸론 유도체
JP2024514006A JP2024535745A (ja) 2021-09-02 2022-09-01 Ampk活性化剤として有用なチアジアゾロン誘導体
AU2022336441A AU2022336441A1 (en) 2021-09-02 2022-09-01 Thiadiazolone derivatives useful as ampk activator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2112529.9A GB202112529D0 (en) 2021-09-02 2021-09-02 New compounds

Publications (1)

Publication Number Publication Date
GB202112529D0 true GB202112529D0 (en) 2021-10-20

Family

ID=78076730

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2112529.9A Ceased GB202112529D0 (en) 2021-09-02 2021-09-02 New compounds

Country Status (11)

Country Link
US (1) US20250136563A1 (cg-RX-API-DMAC7.html)
EP (1) EP4396171A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024535745A (cg-RX-API-DMAC7.html)
KR (1) KR20240055039A (cg-RX-API-DMAC7.html)
CN (1) CN118510762A (cg-RX-API-DMAC7.html)
AU (1) AU2022336441A1 (cg-RX-API-DMAC7.html)
CA (1) CA3230307A1 (cg-RX-API-DMAC7.html)
GB (1) GB202112529D0 (cg-RX-API-DMAC7.html)
IL (1) IL310871A (cg-RX-API-DMAC7.html)
MX (1) MX2024002674A (cg-RX-API-DMAC7.html)
WO (1) WO2023031609A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3075388T3 (en) 2019-10-18 2026-08-04 Betagenon Ab New formulations
GB202015585D0 (en) 2020-10-01 2020-11-18 Betagenon Bio Ab New compounds
WO2025252672A1 (en) * 2024-06-03 2025-12-11 Betagenon Ab Use of tryptophan and metabolites thereof as biomarkers for treatment methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200720264A (en) * 2005-04-25 2007-06-01 Lundbeck & Co As H Pro-drugs of n-thiazol-2-yl-benzamide derivatives
US20090156644A1 (en) * 2005-07-21 2009-06-18 Jacob Westman Use of thiazole derivatives and analogues in the treatment of cancer
AU2010270030B2 (en) * 2009-07-08 2015-12-24 Baltic Bio Ab 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer
JP2013230986A (ja) * 2010-08-25 2013-11-14 Kyorin Pharmaceutical Co Ltd 新規ヒダントイン誘導体及びそれらを有効成分とする医薬
KR101889993B1 (ko) * 2010-09-10 2018-08-20 시오노기세야쿠 가부시키가이샤 Ampk 활성화 작용을 갖는 헤테로환 축합 이미다졸 유도체
WO2013108026A1 (en) * 2012-01-17 2013-07-25 Baltic Bio Ab Thiadiazolone derivatives useful in the treatment of diabetes
CN111848579B (zh) * 2019-04-26 2023-11-14 君实润佳(上海)医药科技有限公司 4-(2,6-二氯苯甲酰氨基)-n-(4-哌啶基)-1h-吡唑-3-甲酰胺的前药
GB202015585D0 (en) * 2020-10-01 2020-11-18 Betagenon Bio Ab New compounds

Also Published As

Publication number Publication date
US20250136563A1 (en) 2025-05-01
IL310871A (en) 2024-04-01
EP4396171A1 (en) 2024-07-10
CA3230307A1 (en) 2023-03-09
AU2022336441A1 (en) 2024-03-07
WO2023031609A1 (en) 2023-03-09
CN118510762A (zh) 2024-08-16
JP2024535745A (ja) 2024-10-02
MX2024002674A (es) 2024-03-19
KR20240055039A (ko) 2024-04-26

Similar Documents

Publication Publication Date Title
EP4452937A4 (en) CONNECTIONS
GB202013721D0 (en) New compounds
GB202015585D0 (en) New compounds
GB202104039D0 (en) New compounds
GB202001564D0 (en) Compounds
GB202104038D0 (en) New compounds
GB202104033D0 (en) New compounds
GB202113583D0 (en) New compounds
GB202109946D0 (en) New compounds
GB202107406D0 (en) New Compounds
GB202104040D0 (en) New compounds
GB202101620D0 (en) New compounds
GB202101600D0 (en) New compounds
GB202101609D0 (en) New compounds
GB202101614D0 (en) New compounds
GB202101621D0 (en) New compounds
GB202101602D0 (en) New compounds
GB202101617D0 (en) New compounds
GB202101616D0 (en) New compounds
GB202101607D0 (en) New compounds
GB202012871D0 (en) New compounds
GB202009083D0 (en) New compounds
GB202008158D0 (en) New compounds
GB202001869D0 (en) New compounds
GB202001646D0 (en) New compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)